Asceneuron Pty Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease (NCT04759365) | Asceneuron Pty Ltd. | 2021-06-02 |
Track Asceneuron Pty Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.